Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View AllMSN features Dr. Brian Dixon
Brian Dixon, PhD, MPA, was featured on MSN about a...
Influence
View AllPrevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers
Published in the journal JAMA Network Open. Here is a...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
February 22, 2023
Dr. Boustani in Clinical Research News
"*" indicates required fields